Home›Stock Screener›Kronox Lab Sciences›Financial Statements

Kronox Lab Sciences Complete Financial Statements

7 Years of Data
2026 - 2020

In FYNone, Kronox Lab Sciences (KRONOX) reported revenue ₹111 Cr, net profit ₹29 Cr and EPS ₹7.80, with a net profit margin of 27.7% and ROE of 24.1%. Full financial statements from FY2020 to FY2026 (7 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. View KRONOX 52-week chart for the annual high/low range and current price position.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 27.72% 2026 data
EBITDA Margin 33.66% 2026 data
Operating Margin 34.00% 2026 data
Return on Assets 21.88% 2026 data
Return on Equity 24.14% 2026 data

Balance Sheet Ratios

Current Ratio 79.00 2026 data
Equity Ratio 90.63% 2026 data
Asset Turnover 0.79 2026 data

KRONOX Revenue, Net Profit & EBITDA — Year-on-Year Growth

KRONOX YoY (March 2026 vs Period) — revenue +9.9%, net profit +3.6%, EBITDA +20.6%, expenses +4.5%. For live price, earnings ratios and company overview, see KRONOX share price.

Revenue Growth
+9.9%
Year-over-Year
Net Profit Growth
+3.6%
Year-over-Year
EBITDA Growth
+20.6%
Year-over-Year
Expense Growth
+4.5%
Year-over-Year
Assets Growth
+29.3%
Year-over-Year
Equity Growth
+28.9%
Year-over-Year
Operating Cash Flow Growth
+82.4%
Year-over-Year
Investing Cash Flow Growth
-64.7%
Year-over-Year

KRONOX Income Statement — Revenue, EBITDA & Net Profit

Kronox Lab Sciences revenue ₹111 Cr, EBITDA ₹41 Cr, net profit ₹29 Cr, EPS ₹7.80 (None) — net profit margin 27.7%. Check Kronox Lab Sciences networth to track the company's total market size over time.

Periods ₹ Crores
Particulars None March 2026 March 2025 March 2024 March 2023 March 2022 March 2021 March 2020
Revenue 111 101 103 91 98 83 63 52
Expenses 70 67 67 62 74 63 48 39
EBITDA 41 34 36 30 24 21 16 13
Operating Profit Margin % 33.00% 34.00% 33.00% 32.00% 23.00% 24.00% 24.00% 23.00%
Depreciation 2 2 1 1 2 2 2 1
Interest 0 0 0 0 0 0 0 0
Profit Before Tax 39 37 34 29 22 18 13 12
Tax 10 10 9 7 6 5 4 3
Net Profit 29 28 26 21 16 14 10 9
Earnings Per Share (₹) 7.80 7.51 6.91 5.81 4.29 3.49 2.40 343.75

KRONOX Balance Sheet — Assets, Liabilities & Shareholders' Equity

KRONOX total assets ₹128 Cr, total equity ₹116 Cr, total liabilities ₹ Cr (2026) — ROE 24.1%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021 2020
ASSETS
Total Assets 128 99 74 54 57 38 34
Current Assets 79 63 47 34 44 26 27
Fixed Assets 30 28 26 16 11 9 6
Capital Work in Progress 1 1 1 0 0 0 0
Investments 8 0 0 0 0 0 0
Other Assets 0 70 47 38 46 28 29
LIABILITIES
Total Liabilities
Current Liabilities 1 0 0 1 3 3 0
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 116 90 66 45 40 27 23
Share Capital 37 37 37 37 0 0 0
Reserves & Surplus 79 53 29 8 40 27 23

KRONOX Cash Flow Statement — Operating, Investing & Financing

Kronox Lab Sciences operating cash flow ₹31 Cr, investing ₹-28 Cr, financing ₹-2 Cr, net cash flow ₹0 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020
Operating Activities 31 17 20 9 11 5
Investing Activities -28 -17 -7 -8 -3 -4
Financing Activities -2 0 -13 -1 -7 0
Net Cash Flow 0 0 0 1 1 0